161Tb-PSMA-I&T and177Lu-PSMA-I&T treatment in T23 and ST4787 prostate cancer cell lines - a model representative of177Lu-PSMA-resistant prostate cancer phenotype

被引：0
|
作者：
Kirienko, M. [1 ]
Jachetti, E. [1 ]
Sulsenti, R. [1 ]
Pascali, C. [1 ]
Bogni, A. [1 ]
Colombo, M. [1 ]
Seregni, E. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0010
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [21] 177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
    Karimzadeh, Amir
    Heck, Matthias
    Tauber, Robert
    Knorr, Karina
    Haller, Bernhard
    D'Alessandria, Calogero
    Weber, Wolfgang A.
    Eiber, Matthias
    Rauscher, Isabel
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (03) : 402 - 409
  • [22] Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Feuerecker, Benedikt
    Chantadisai, Maythinee
    Allmann, Anne
    Tauber, Robert
    Allmann, Jakob
    Steinhelfer, Lisa
    Rauscher, Isabel
    Wurzer, Alexander
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    d'Alessandria, Calogero
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 833 - 839
  • [23] Preliminary Results of Lu-177 PSMA I&T Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Hekimsoy, T.
    Gorur, G. Daglioz
    Isgoren, S.
    Demir, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S592 - S593
  • [24] Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer
    Eiber, Matthias
    Heck, Matthias
    Tauber, Robert
    Rauscher, Isabel
    D'Alessandria, Calogero
    Maurer, Tobias
    Retz, Margitta
    Wester, Hans
    Schwaiger, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [25] The correlation between PSMA PET/CT uptake and [177Lu]Lu-PSMA-I&T absorbed dose in Metastatic Castration-Resistant Prostate Cancer Patients.
    Kalloe, V.
    Owers, E. C.
    de Boer, M. M.
    Rijkhorst, E.
    Aalbersberg, E. A.
    Dotinga, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S424 - S424
  • [26] Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
    Heck, Matthias M.
    Tauber, Robert
    Schwaiger, Sebastian
    Retz, Margitta
    D'Alessandria, Calogero
    Maurer, Tobias
    Gafita, Andrei
    Wester, Hans-Juergen
    Gschwend, Juergen E.
    Weber, Wolfgang A.
    Schwaiger, Markus
    Knorr, Karina
    Eiber, Matthias
    EUROPEAN UROLOGY, 2019, 75 (06) : 920 - 926
  • [27] Radioligand Therapy With 177Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer Oncological Outcomes and Toxicity Profile
    Demirkol, Mehmet Onur
    Esen, Baris
    Seymen, Huelya
    Sen, Melis
    Ucar, Burcu
    Kurtuldu, Sevgilay
    Mandel, Nil Molinas
    Bavbek, Sevil
    Falay, Okan
    Tilki, Derya
    Esen, Tarik
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : E564 - E569
  • [28] Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
    Schuchardt, Christiane
    Zhang, Jingjing
    Kulkarni, Harshad R.
    Chen, Xiaoyuan
    Mueller, Dirk
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1199 - 1207
  • [29] Intensified therapy with 177Lu-PSMA-I&T in patients with high-volume metastatic castration-resistant prostate cancer
    Mader, Nicolai
    Haghghi, Sarvar
    Klimek, Konrad
    Schoeler, Christina
    Sarvestani, Mohammadreza Kamali
    Roedel, Claus
    Chun, Felix K. H.
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [30] 177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
    Derlin, Thorsten
    Widjaja, Liam
    Werner, Rudolf A.
    Bengel, Frank M.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (01) : 54 - 58
12345